A detailed history of Quantbot Technologies LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Quantbot Technologies LP holds 769 shares of NBIX stock, worth $96,517. This represents 0.0% of its overall portfolio holdings.

Number of Shares
769
Holding current value
$96,517
% of portfolio
0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$114.58 - $153.15 $88,112 - $117,772
769 New
769 $88,000
Q1 2024

May 06, 2024

SELL
$130.4 - $143.74 $217,116 - $239,327
-1,665 Reduced 98.46%
26 $3,000
Q4 2023

Feb 14, 2024

SELL
$106.07 - $132.76 $57,065 - $71,424
-538 Reduced 24.14%
1,691 $222,000
Q3 2023

Nov 07, 2023

BUY
$94.02 - $117.1 $148,645 - $185,135
1,581 Added 243.98%
2,229 $250,000
Q2 2023

Aug 08, 2023

BUY
$89.53 - $104.87 $4,655 - $5,453
52 Added 8.72%
648 $61,000
Q1 2023

May 12, 2023

SELL
$94.11 - $123.02 $285,059 - $372,627
-3,029 Reduced 83.56%
596 $60,000
Q4 2022

Feb 13, 2023

BUY
$106.72 - $127.06 $386,860 - $460,592
3,625 New
3,625 $432,000
Q2 2022

Aug 09, 2022

BUY
$75.79 - $100.07 $106,939 - $141,198
1,411 New
1,411 $137,000
Q1 2022

May 16, 2022

SELL
$72.45 - $94.81 $249,735 - $326,810
-3,447 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$79.65 - $106.22 $234,409 - $312,605
2,943 Added 583.93%
3,447 $293,000
Q3 2021

Nov 09, 2021

BUY
$86.18 - $99.03 $43,434 - $49,911
504 New
504 $48,000
Q1 2021

May 14, 2021

SELL
$87.57 - $119.4 $9,194 - $12,537
-105 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$86.91 - $108.33 $491,389 - $612,497
-5,654 Reduced 98.18%
105 $10,000
Q3 2020

Nov 16, 2020

BUY
$96.16 - $135.15 $440,412 - $618,987
4,580 Added 388.46%
5,759 $553,000
Q2 2020

Aug 13, 2020

BUY
$85.09 - $130.36 $91,812 - $140,658
1,079 Added 1079.0%
1,179 $143,000
Q1 2020

May 13, 2020

SELL
$75.11 - $113.76 $450,434 - $682,218
-5,997 Reduced 98.36%
100 $8,000
Q4 2019

Feb 10, 2020

BUY
$86.8 - $118.57 $282,794 - $386,301
3,258 Added 114.76%
6,097 $655,000
Q3 2019

Nov 12, 2019

BUY
$83.82 - $101.5 $53,560 - $64,858
639 Added 29.05%
2,839 $255,000
Q2 2019

Aug 13, 2019

SELL
$72.24 - $91.27 $116,523 - $147,218
-1,613 Reduced 42.3%
2,200 $185,000
Q1 2019

May 13, 2019

BUY
$69.31 - $91.53 $224,217 - $296,099
3,235 Added 559.69%
3,813 $335,000
Q4 2018

Feb 13, 2019

SELL
$68.32 - $124.36 $92,163 - $167,761
-1,349 Reduced 70.01%
578 $41,000
Q3 2018

Nov 13, 2018

BUY
$98.88 - $125.85 $190,541 - $242,512
1,927 New
1,927 $236,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.